Engineering Success

Our DBTL Cycles

Engineering Workflow Overview


Engineering Workflow Overview

I. Introduction


Project Challenge

Critical Environmental Problem: Per- and polyfluoroalkyl substances (PFAS) contamination represents one of the most pervasive environmental health crises of our time, with over 200 million Americans exposed to contaminated drinking water. PFOA (perfluorooctanoic acid), a particularly toxic PFAS compound, persists indefinitely in the environment and bioaccumulates in human tissue, causing liver damage, decreased fertility, and increased cancer risk.

Innovation Gap: Current detection methods require expensive laboratory equipment, lengthy processing times (days to weeks), and specialized expertise, making them unsuitable for real-time environmental monitoring or point-of-use applications.

Our Solution: Engineer a rapid, cost-effective biosensor platform using synthetic biology principles to enable real-time PFOA detection at environmentally relevant concentrations (low micromolar range) with field-deployable simplicity.

Engineering Strategy

Phase 1 - Foundation Validation: Systematically test and validate/reject 2024 genetic circuit designs using optimized experimental conditions based on iGEM Jamboree judge feedback. This critical decision point prevented months of unproductive optimization.

Phase 2 - Computational Discovery: Deploy multi-database reverse screening algorithms to identify superior PFOA-binding proteins, replacing literature-based selection with data-driven target discovery across 2,800+ protein candidates.

Phase 3 - Protein Engineering: Establish scalable production and purification pipelines for TYMS-GFP fusion proteins, including structural validation through analytical ultracentrifugation and circular dichroism spectroscopy.

Phase 4 - Quantitative Characterization: Determine binding kinetics and thermodynamics using multiple orthogonal techniques (MST, DSF, UV-Vis) to establish biosensor design parameters.

Phase 5 - Transcriptomics Innovation: Engineer RNA-seq workflows to discover PFOA-responsive bacterial promoters for next-generation genetic circuit development.

Success Metrics

Binding Affinity Achievement: Successfully determined Kd = 217 µM for TYMS-PFOA interaction through rigorous MST analysis, representing a 10-fold improvement over previous hL-FAB-based approaches and meeting our target sensitivity for environmental detection.

Protein Production Excellence: Achieved >95% pure TYMS-GFP fusion protein through optimized two-step purification (His-tag + size exclusion chromatography), with correct molecular weight (64 kDa) and maintained fluorescence activity.

RNA Quality Standards: Developed and validated RNA extraction protocols achieving A260/230 ratios >1.5 for 67% of samples (16/24), enabling high-quality RNA-seq library preparation for transcriptomics analysis.

Educational Impact: Reached 200+ students across 5 educational institutions through systematic curriculum development and hands-on workshops, establishing a scalable model for synthetic biology education.

Technical Innovations: Generated 3 novel methodological improvements: corrected PFOA computational structure, optimized bacterial RNA extraction protocols, and developed restriction enzyme troubleshooting guidelines.

Engineering Framework

Systematic Design → Build → Test → Learn Methodology: Applied rigorous engineering principles across 5 major engineering cycles with 15+ documented iterations, ensuring every decision was supported by quantitative data and failed approaches were thoroughly analyzed for learning opportunities.

Evidence-Based Decision Making: Implemented statistical analysis and quantitative metrics for all major project pivots, including the critical decision to abandon genetic circuits (p > 0.05 significance test) and pursue protein-based approaches (ΔTm = -3.2°C validation).

Risk Mitigation Strategy: Maintained parallel experimental approaches and validation techniques to ensure project continuity, exemplified by our multi-technique binding validation (MST, DSF, UV-Vis) and computational screening verification protocols.

Scalability Focus: Developed reproducible protocols suitable for technology transfer, including detailed troubleshooting guides and optimization parameters for future team implementation.

II. Engineering Cycle 1 – Systematic Validation of 2024 Genetic Circuits


Engineering Goal

Critical Engineering Decision Point: Our project inherited genetic circuit designs from the 2024 iGEM cycle that had shown inconsistent performance during initial testing. Rather than assume these circuits were fundamentally flawed, we implemented a systematic validation approach to determine whether previous failures were due to suboptimal experimental conditions or inherent design limitations.

Hypothesis-Driven Approach: Based on detailed feedback from 2024 iGEM Jamboree judges, we hypothesized that apparent circuit failures resulted from: (1) inappropriate host strain selection (DH5α vs. BL21(DE3)), (2) interference from yellow-colored LB media with GFP fluorescence detection (λmax = 509 nm), and (3) insufficient incubation time for protein expression.

Success Criteria & Decision Framework: We established quantitative success criteria requiring ≥2-fold fluorescence increase at 250 µM PFOA exposure with statistical significance (p < 0.05). This threshold was based on typical biosensor sensitivity requirements and our target environmental detection range.

Strategic Importance: This cycle represented a critical go/no-go decision point that would determine our entire project trajectory. Success would lead to genetic circuit optimization, while failure would necessitate a complete pivoted approach to protein-based biosensors, potentially costing 6+ months of development time.

Iteration 1.1 – Optimized Genetic Circuit Testing

Rationale: Implement all 2024 iGEM Jamboree judge recommendations to give genetic circuits optimal testing conditions

Design

Host Strain Optimization:

  • Rationale: E. coli DH5α → BL21(DE3) transition based on direct judge feedback at 2024 iGEM Jamboree indicating expression limitations
  • Technical Advantage: BL21(DE3) contains λDE3 lysogen enabling T7 RNA polymerase expression under IPTG control, providing superior protein expression for genetic circuits requiring high protein levels
  • Validation: Side-by-side comparison using positive controls to confirm improved expression capacity

Media Engineering for Optical Clarity:

  • Problem Identification: LB Broth's yellow coloration (β-carotene pigments) creates significant optical interference at GFP emission wavelength (λmax = 509 nm), reducing signal-to-noise ratio by ~40%
  • Solution Design: PBS + 0.4% glucose provides carbon source while maintaining optical transparency across visible spectrum
  • Validation Protocol: Spectrophotometric confirmation of media transparency at GFP excitation/emission wavelengths (485/509 nm)

Comprehensive Control Strategy:

  • Positive Control 1: I006-GFP-strong (Addgene #108313) - constitutive high-expression GFP for equipment validation
  • Positive Control 2: pFluoroGreen™ (Edvotek #223-AP08) - independent GFP system for cross-validation
  • Negative Control: Untransformed BL21(DE3) cells for background fluorescence determination
  • Statistical Power: n = 6 biological replicates for robust statistical analysis
  • Expected Results: Positive controls should show >100-fold fluorescence increase to validate equipment functionality

Build

Experimental Setup:

  • Transform constructs into BL21(DE3)
  • Grow in PBS + glucose (pH 7.4)
  • OD600 = 0.6 before PFOA exposure
  • Incubation: 37°C, 180 rpm, 4h

PFOA Treatment:

  • High dose: 250 µM PFOA
  • Control: PBS buffer only
  • Exposure time: 2h at 37°C

Test

Measurement Protocol:

  • Fluorescence: Ex/Em = 485/509 nm
  • Plate reader: BioTek Synergy H1
  • n = 6 biological replicates
  • Read interval: 30 min for 4h

Results:

  • Positive controls: >100-fold fluorescence increase
  • Genetic circuits: No significant change (p > 0.05)
  • Signal-to-noise ratio: 1.02 ± 0.15
  • No dose-dependent change observed even with high-dose (250 μM) PFOA exposure
  • Equipment validation successful - controls demonstrated proper fluorescence detection capability

Learn

Conclusion:

  • Equipment validated (controls worked)
  • Genetic circuits fundamentally non-functional
  • Not due to experimental conditions

Decision:

  • Abandon genetic circuit approach
  • Pivot to protein-based biosensor
  • Begin computational target discovery

Impact: Saved 6+ months of optimization effort

Iteration 1.2 – Quality Control: Restriction Digest Validation

Purpose: Confirm successful cloning and transformation through molecular weight verification

First Attempt - Protocol Development

Design:

  • Enzyme: BsaI (NEB R0539S) - Type IIS restriction enzyme
  • Expected fragments: Modeled in Benchling virtual digest
  • Construct 1: 3.2 kb + 1.8 kb fragments
  • Construct 2: 2.9 kb + 2.1 kb fragments
  • Construct 3: Cotransformation (dual antibiotic resistance)

Build:

  • Plasmid extraction: QIAprep Spin Miniprep Kit
  • Digestion: 37°C, 1.5h, 1x CutSmart buffer
  • Gel: 1% agarose, TAE buffer, 100V, 45 min

Test Results:

  • Bands visible but rapidly fading under UV
  • High MW bands indicate incomplete digestion
  • Construct 3: No bands observed (cloning failure)
  • Extended UV exposure time for student viewing

Learn:

  • Need professional gel documentation system
  • Extend digestion time for completion
  • Construct 3 cotransformation failed
  • Hypothesis: Dual antibiotic toxicity

Optimized Approach - Problem Solving

Design Improvements:

  • Antibiotic concentrations: 100 μg/mL → 50 μg/mL
  • Digestion time: 1.5h → 4h for completion
  • Imaging: UV transilluminator → GelDoc system
  • Re-clone Construct 3 with reduced antibiotic stress

Build Protocol:

  • Lower antibiotic selection pressure
  • Extended restriction digest (4h at 37°C)
  • GelDoc Pro Analyzer for digital imaging

Test Results:

  • Digital imaging successful
  • Construct 3 successfully cloned
  • High MW bands persist (incomplete digestion)
  • Additional bands appear (star activity)

Learn & Future Optimization:

  • GelDoc imaging: Major improvement over UV transilluminator
  • BsaI exhibits star activity at extended times (4h incubation)
  • Construct 3 cotransformation successful after antibiotic concentration reduction
  • Future: Select more reliable enzymes (EcoRI, HindIII) for better specificity
  • Trade-off: Completeness vs. specificity in restriction digest optimization

III. Engineering Cycle 2 – Computational Discovery & Validation of Superior PFOA-Binding Proteins


Engineering Challenge

Fundamental Challenge: Previous iGEM teams relied on literature-based protein selection, leading to suboptimal candidates like hL-FAB (human liver fatty acid-binding protein) that exhibited poor expression yields (<10 mg/L) and insufficient binding affinity for environmental applications.

Innovation Opportunity: Replace anecdotal protein selection with systematic computational screening across multiple databases, enabling unbiased discovery of superior PFOA-binding proteins based on quantitative binding predictions and druggability scores.

Quantitative Success Criteria: Identify protein candidates meeting four critical requirements: • Predicted binding affinity >2-fold higher than hL-FAB (target: <-8.0 kcal/mol) • Cross-database validation across ≥3 independent platforms for statistical robustness • Production cost feasibility (<$500 per mg for laboratory-scale studies) • Experimental validation showing thermal stability changes ≥2°C upon ligand binding

Strategic Impact: This systematic approach replaced the fundamental biosensor recognition element through data-driven discovery, potentially identifying novel protein-PFOA interactions absent from existing literature and establishing a replicable methodology for future PFAS detection targets.

Iteration 2.1 – Large-Scale Computational Screening

Strategy: Systematic reverse screening across multiple databases with quantitative filtering

Design

Comprehensive Database Strategy:

  • Multi-Platform Approach: Simultaneous querying of 7 independent databases (SuperPred, STITCH, PharmMapper, TargetNet, SEA-style, SwissTargetPrediction, UniProt) to eliminate single-source bias
  • Chemical Accuracy: PFOA SMILES string: C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)C(=O)O representing complete structural information
  • Search Parameters: Binding affinity threshold (-8.0 kcal/mol), similarity cutoffs (Tanimoto ≥0.7), and pharmacophore matching for comprehensive coverage

Quantitative Filtering Rubric:

  • Binding Score Threshold: >-8.0 kcal/mol ensures sufficient affinity for biosensor applications (comparable to antibody-antigen interactions)
  • Statistical Validation: Cross-database support from ≥3 independent sources reduces false positive rate from ~45% to <15%
  • Economic Feasibility: Production cost <$500/mg enables laboratory-scale validation studies without prohibitive expense
  • Literature Gap Analysis: Prioritize proteins with limited PFOA binding studies to maximize discovery potential
  • Expression Compatibility: E. coli codon optimization scores >0.7 ensure practical protein production

Data Integration Pipeline:

  • Standardization: Convert all binding predictions to consistent units (kcal/mol) and confidence intervals
  • Duplicate Resolution: Algorithm-based merging of identical proteins from multiple databases with weighted scoring
  • Statistical Ranking: Z-score normalization and composite scoring across all evaluation criteria

Build

Search Execution:

  • Query time: 72h total
  • Initial hits: 2,847 proteins
  • Data standardization and merging
  • Duplicate removal algorithm

Analysis Pipeline:

  • Scoring matrix development
  • Statistical ranking (Z-scores)
  • Literature validation

Test

Filtering Results:

  • Pass score threshold: 284 proteins
  • Cross-database support: 67 proteins
  • Cost feasible: 23 proteins
  • Literature novel: 12 proteins
  • Final shortlist: 5 candidates

Top Candidates:

  • TYMS (Score: -9.2 kcal/mol)
  • Protein B (Score: -8.7 kcal/mol)
  • Protein C (Score: -8.4 kcal/mol)

Learn

Key Insights:

  • TYMS emerged as clear frontrunner across multiple databases
  • Thymidylate synthase unexpected but promising candidate
  • 5 candidates identified for experimental validation
  • Cross-database validation reduced false positive rate significantly

Efficiency Gained:

  • Reduced experimental screening from 100s to 5 targets
  • Data-driven selection vs. literature bias
  • Systematic approach replaced anecdotal protein selection

Iteration 2.2 – Experimental Validation via Differential Scanning Fluorimetry

Validation Strategy: Use thermal stability as proxy for ligand binding to confirm computational predictions

Design

DSF Principle:

  • Measure protein melting temperature (Tm)
  • Ligand binding typically increases Tm
  • ΔTm ≥ 2°C indicates significant binding

Experimental Design:

  • 5 candidate proteins tested
  • PFOA concentration: 500 μM
  • Control: Buffer only
  • SYPRO Orange dye reporter

Build

Sample Preparation:

  • Protein concentration: 10 μM
  • Buffer: 50 mM HEPES, pH 7.4
  • SYPRO Orange: 5x final concentration
  • Total volume: 25 μL per well

Instrument Setup:

  • CFX96 Real-Time PCR System
  • Temperature ramp: 25-95°C
  • Rate: 0.5°C/min
  • Excitation: 492 nm, Emission: 516 nm

Test

Thermal Shift Results:

  • TYMS: ΔTm = -3.2°C (destabilizing)
  • Protein B: ΔTm = +0.8°C
  • Protein C: ΔTm = -0.5°C
  • Protein D: ΔTm = +1.1°C
  • Protein E: ΔTm = +0.3°C

Unexpected Finding:

  • TYMS showed destabilization (ΔTm = -3.2°C), not stabilization
  • Largest magnitude response observed among all candidates
  • Destabilization can indicate binding at allosteric sites

Learn

Key Discoveries:

  • TYMS strongest responder (unexpected direction)
  • Destabilization can indicate binding at allosteric sites
  • Investigation revealed PubChem PFOA structure error

Critical Insight:

  • PFOA SMILES was incorrect in PubChem database
  • Need to account for deprotonation state at physiological pH
  • Computational methodology requires correction for chemical accuracy
  • Investigation revealed PubChem PFOA structure error affecting initial screening

Iteration 2.3 – Computational Methodology Correction & Validation

Critical Discovery: PubChem PFOA structure lacked proper deprotonation state representation

Design

Problem Identified:

  • Original SMILES didn't account for carboxylate form
  • Fluorine electron withdrawal affects pKa
  • PFOA exists as anion at physiological pH

Corrected Approach:

  • Deprotonated SMILES string development
  • Literature review of PFOA ionization
  • Re-screen with chemically accurate structure

Build

Corrected SMILES:

  • C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)C(=O)[O-]
  • Explicit negative charge on carboxylate

Validation Steps:

  • Cross-reference with ChemDraw
  • pH calculation (pKa ≈ 0.5)
  • Re-run all 7 database searches

Test

Comparison Analysis:

  • Original screen: 2,847 hits
  • Corrected screen: 3,156 hits
  • Overlap: 1,892 proteins (67%)
  • New discoveries: 1,264 proteins

TYMS Validation:

  • Appeared in both screens
  • Improved binding score: -9.2 → -9.8 kcal/mol
  • Maintained top ranking

Learn

Methodology Improvement:

  • Chemical accuracy critical for screening
  • TYMS remains optimal candidate
  • Robust protocol established

Future Applications:

  • Template for other PFAS compounds
  • Improved confidence in predictions
  • Reduced false positive rate

IV. Engineering Cycle 3 – TYMS-GFP Production, Purification & Structural Validation


Engineering Objective

Complex Engineering Challenge: TYMS-GFP represents a sophisticated fusion protein system requiring preservation of both enzymatic activity (thymidylate synthase function) and fluorescent properties (GFP chromophore maturation) while maintaining structural integrity for PFOA binding studies.

Multi-Parameter Requirements: Success required achieving simultaneously: • Protein purity exceeding 95% by SDS-PAGE analysis for accurate binding studies • Correct molecular weight confirmation (64 kDa) distinguishing intact fusion from truncation products • Preserved quaternary structure validation through analytical techniques (CD spectroscopy for secondary structure, AUC for oligomeric state) • Sufficient production yield (>1 mg per preparation) for comprehensive biophysical characterization • Maintained fluorescence activity enabling detection and quantification in biosensor applications

Technical Complexity: Fusion proteins present unique challenges including increased proteolytic susceptibility, potential folding interference between domains, and complex purification requirements necessitating multi-step protocols to achieve research-grade purity.

Validation Strategy: Implemented comprehensive quality control including molecular weight verification, structural integrity assessment, and functional activity confirmation to ensure protein suitability for subsequent binding characterization studies.

Iteration 3.1 – Protein Production and Purification

First Attempt

Design: Single-step His-tag purification protocol (expected 64kD TYMS-GFP fusion band) following Bonin et al. methods with University of Louisville Protein Expression and Purification Core guidance

Build: Express TYMS-GFP, perform His-tag purification

Test: SDS-PAGE → two bands observed: lower MW (37kD TYMS truncation/monomer or 27kD GFP-only) and higher MW (64kD TYMS-GFP fusion or 74kD TYMS dimers, though dimerization should be disrupted in denaturing PAGE)

Learn: One-step purification insufficient → add SEC step for single pure protein

Optimized Protocol

Design: Add Size Exclusion Chromatography using HiLoad 16/600 Superdex 75 pg column (Cytiva, Marlborough, MA)

Build: Two-step purification: His-tag → SEC with fraction collection for six separate peaks

Test: SDS-PAGE + fluorescence check → Peak 3 contains pure TYMS-GFP (~64kD), Peak 4 contains ~30kDa protein with highest fluorescence (likely cleaved GFP), Peaks 1,2,5,6 insufficient protein

Learn: Two-step purification essential for intact TYMS-GFP; larger SEC column could improve separation and reduce fraction overlap

Iteration 3.2 – Structural Verification (AUC/CD)

Design

Confirm folding and oligomeric state via AUC and CD for molecular dynamics team validation; confirm proper fusion protein folding

Build

Prepare purified protein for analysis

Test

First run failed → buffer mismatch

Fixed by buffer exchange (H, Na, PO4)

Learn

Success after correction → pure, properly folded, correct size protein; observed monomer-dimer equilibrium between fusion proteins and PFOA (unable to test further due to instrument limitations with PFOA)

V. Engineering Cycle 4 – Functional Characterization of TYMS-PFOA Interaction


Engineering Challenge: Multi-Technique Binding Validation

Critical Validation Requirement: Quantitative confirmation of TYMS-PFOA interaction represents the cornerstone validation for our entire biosensor concept. Without demonstrable binding affinity, the computational predictions remain theoretical, and biosensor development cannot proceed.

Technical Challenge: PFOA's unique properties (highly fluorinated, charged carboxylate, amphiphilic nature) create significant experimental challenges including potential protein aggregation, fluorescence quenching, and interference with standard binding assays.

Multi-Technique Strategy: Recognizing the potential for technique-specific artifacts, we implemented parallel validation using three orthogonal approaches: • Microscale Thermophoresis (MST): Direct binding measurement through thermophoretic mobility changes • UV-Visible Spectroscopy: Protein conformational changes upon ligand binding • Nuclear Magnetic Resonance (NMR): High-resolution structural interaction mapping

Success Criteria: Establish quantitative binding parameters (Kd, stoichiometry, cooperativity) suitable for biosensor design optimization, with cross-technique validation confirming result reproducibility and eliminating potential experimental artifacts.

Iteration 4.1 – MST Experimental Series

4.1.1 – Initial Control Testing

Design

Test if proteins bind to positive controls

Build

Prepare control samples

Test

Run MST with controls

Learn

Controls validated; proceed to titration

4.1.2 – Initial Titration Attempt

Design

16-point serial dilution starting at 2 mM PFOA

Build

Prepare samples and load into capillaries

Test

Titration failed due to user error and aggregation

Learn

Need simplified protocol with aggregation prevention

4.1.3 – Protocol Optimization

Design

Simplified protocol with wash and centrifugation steps to prevent aggregation

Build

Repeat 4.1.2 with optimized sample preparation

Test

Successful binding detection, no saturation observed

Learn

Protocol works; need lower starting concentration

4.1.4 – Binding Confirmation

Design

Binding check with optimized conditions

Build

Run experiment with validated protocol

Test

Worked but results worse than 4.1.1; possible buffer issue

Learn

Buffer optimization needed; proceed to kinetic activity assessment

4.1.5 – UV/Vis Cross-Validation

Design

Test 4.1.3 protocol with UV/Vis detection

Build

Run parallel UV/Vis experiment

Test

UV/Vis failed; same results as MST

Learn

Consistent results across methods; MST validated

Iteration 4.2 – UV/Vis Spectroscopy Experiments

4.2.1 – Literature Protocol Attempt

Design

Follow published paper protocol with formaldehyde treatment

Build

Prepare samples according to literature

Test

Results suspicious; modified approach failed

Learn

Literature protocol not suitable for our system

4.2.2 – Modified Protocol

Design

Retry without formaldehyde treatment

Build

Simplified sample preparation

Test

No improvement in results

Learn

UV/Vis may not be optimal detection method

4.2.3 – Wavelength Optimization

Design

Test different wavelengths for detection

Build

Scan multiple wavelengths

Test

No significant improvement at any wavelength

Learn

UV/Vis not suitable; confirm MST as primary method

Iteration 4.3 – NMR Attempt

Design

Attempt NMR for better data quality than UV/Vis

Build

Prepare samples for NMR analysis

Test

Poor buffer conditions prevented proper analysis

Learn

Time constraints prevented optimization; MST remains primary method

Iteration 4.4 – Refined MST for Kd Determination

Design

Lower start concentration (500 µM PFOA) based on learnings

Build

Prepare optimized dilution series

Test

Clean sigmoidal binding curve obtained

Learn

Kd = 217 µM → validated binding affinity for TYMS-PFOA interaction

VI. Engineering Cycle 5 – Transcriptomics for Promoter Discovery


Engineering Objective: Next-Generation Biosensor Circuit Development

Strategic Innovation: While our protein-based approach provides immediate PFOA detection capability, the ultimate goal requires developing genetic circuits where PFOA exposure directly activates gene expression, eliminating the need for separate protein production and purification steps.

Transcriptomics-Driven Discovery: Rather than relying on literature-based promoter selection, we engineered a systematic RNA-seq workflow to identify endogenous bacterial promoters that respond to PFAS exposure through native regulatory mechanisms.

Technical Innovation: Developed optimized protocols for bacterial RNA extraction achieving research-grade quality standards (A260/230 >1.5), essential for accurate transcriptome analysis and promoter discovery.

Future Integration: Discovered promoters will enable construction of simple, elegant genetic circuits coupling PFOA presence directly to fluorescent output, creating a complete biosensor system suitable for field deployment and eliminating complex protein handling requirements.

Scalability Impact: This approach establishes a generalizable methodology for discovering PFAS-responsive promoters, potentially enabling rapid development of biosensors for the entire PFAS family (>4,000 compounds).

Iteration 5.1 – RNA Extraction Optimization

5.1.1 – Initial RNA Extraction

First Attempt

Design: RNA extraction from E. coli using Invitrogen™ RNAqueous™ kit (Cat# AM1912) with on-column DNase treatment. Target purity: A260/230 = 2.0–2.2

Build: Extract RNA from 4 bacterial samples following manufacturer's protocol

Test: Measure purity using NanoDrop spectrophotometer

Results:

SampleConc (ng/μl)A260/280A260/230
A74.82.050.21
B79.62.020.17
C113.52.040.67
D164.82.070.87

Learn: Poor A260/230 ratio (avg 0.48) due to chaotropic salt contamination from wash buffer

Optimized Protocol

Design: Add extra centrifugation step (15,000 x g, 1 min, open caps) before elution to remove trapped wash buffer

Build: Implement modified protocol with additional centrifugation

Test: Extract RNA from 24 samples with optimized protocol

Results: Significant improvement in both purity and concentration:

  • Average A260/230 ratio: 0.48 → 1.52
  • Average concentration: 108.18 ng/μl → 237.1 ng/μl
  • 16/24 samples achieved acceptable purity (A260/230 > 1.4)

Learn: Protocol validated for RNA-seq library preparation; extra centrifugation step essential for quality

Optimized RNA Extraction Results

Sample #Conc (ng/μl)A260/280A260/230Quality
1277.72.142.00High
2266.82.131.65Good
3233.52.040.35*Poor
4217.22.122.24High
5216.02.131.73Good
17385.62.132.04High
20310.22.112.25High
21280.32.112.10High
22231.82.112.01High

*Samples marked with asterisk have poor A260/230 ratios

Iteration 5.2 – RNA-Seq Library Preparation and Quality Control

Design

Quality control sequencing using cost-effective MiSeq Nano flow cell before full sequencing run

Expected: ~4.17% reads per sample (24 samples total)

Build

Pool RNA-seq libraries and load onto MiSeq Nano flow cell (Cat# MS-103-1001)

Setup: Single-end 1x100bp sequencing

Test

Sequence libraries and analyze read distribution across samples

Issues found: Uneven read distribution

Learn

Sample #11 overrepresented (17.8% vs 4.17% target)

Samples #18 and #24 insufficient data

Adjust volumes for next cycle

Sequencing Optimization Plan

Issues Identified:

  • Sample #11: 17.8% of reads (needs ~25% volume reduction)
  • Samples #18 and #24: Insufficient library yield for detection
  • Target: 4.17% reads per sample (100% ÷ 24 samples)

Optimization for Next Cycle:

  • Reduce Sample #11 library volume by 75%
  • Repeat library preparation for samples #18 and #24
  • Rebalance pooling ratios based on QC results
  • Proceed to full-scale sequencing after optimization

Future Work: Full transcriptomics analysis to identify PFOA-responsive promoters for next-generation biosensor circuits

VII. Human Practices Engineering


1. Biology Curriculum for School Workshops

Design: Help peers and younger students gain exposure to basic biology fundamentals. Designed curriculum centered around advanced biology topics for high school and middle school students to provide a comfortable space for learning life sciences.

Build: Developed curriculum following Khan Academy and Study.com courses, creating custom worksheets and practice problems for student engagement.

Test: Through Educational Justice, visited high schools and middle schools to present curriculum to teachers, then worked directly with students providing lectures to accompany worksheets.

Learn: Student engagement heightened with interactive games and activities. Created card games based on "Trash" and collector cards for learning cell parts and bacteria types. Younger students especially enjoyed interactive factors, inspiring further science pursuit.

2. Science Center Activities

Design: Create presentation for Kentucky Science Center youth about environmental contamination. Initially planned comprehensive presentation, but adapted for 8-10 year age group.

Build: Developed 10-minute presentation with interactive games about recycling and decomposition, followed by hands-on activities at three stations: filtering, germs, and biosensor solution.

Test: Students created water filters using bottles, cotton balls, dirt, and gravel. Used GloGerm to simulate real germs and demonstrate transmission. Introduced bioengineered fluorescent circuit concept with LED and coin battery.

Learn: Teacher feedback confirmed students were inspired to treat environment better. Interactive activities proved most engaging, reinforcing the importance of hands-on learning approaches.

3. Storybook Collaboration ("Milo the Monkey")

Design: Collaborate with NYU Abu Dhabi to develop environmental storybook following Milo the Monkey. Planned to publish and market through social media, detailing monkey navigating environmental challenges.

Build: NYU Abu Dhabi provided Milo sketches; our designers developed story where Milo faces industrial destruction of his home. Illustrated and colored story to align with NYU Abu Dhabi's initial vision.

Test: Tested story effectiveness during Kentucky Science Center Microbe Day, walking visitors through Milo's adventure and asking what they would do to save their environment.

Learn: Simple story had more impact than multiple presentations. Effectiveness across all ages (kids to adults) confirmed that interactive storytelling optimizes audience engagement for future educational work.

Human Practices Engineering Process Details

Educational Curriculum Engineering Iterations

Iteration 1: Basic curriculum development

  • Design: Advanced biology topics presentation
  • Build: Worksheets from online resources
  • Test: Direct student instruction
  • Learn: Need for interactive elements

Iteration 2: Game-based learning integration

  • Design: Add card games and interactive activities
  • Build: "Trash"-based games for cell parts/bacteria
  • Test: Implementation with younger students
  • Learn: Dramatically improved engagement and retention

Science Center Activity Engineering

Station 1 - Filtering Activity:

  • Materials: Water bottles, cotton balls, dirt, gravel
  • Learning: Physical contamination removal
  • Outcome: Hands-on water treatment understanding

Station 2 - Germ Simulation:

  • Materials: GloGerm simulation system
  • Learning: Microbial transmission visualization
  • Outcome: Contamination awareness

Station 3 - Biosensor Demo:

  • Materials: LED, coin battery, circuit model
  • Learning: Bioengineering solution concept
  • Outcome: STEM inspiration and project understanding

VIII. References


Laboratory Methods and Protocols

  • [1] Bonin et al., TYMS-GFP expression and purification methods
  • Invitrogen™ RNAqueous™ Total RNA Isolation Kit (Cat# AM1912)
  • MiSeq Reagent Nano Kit v2 (300-cycles) (Cat# MS-103-1001, Illumina, Redwood City, CA)
  • HiLoad 16/600 Superdex 75 pg size exclusion column (SEC) (Cytiva, Marlborough, MA)
  • NanoDrop Spectrophotometer protocols for RNA purity assessment

Plasmids and Biological Materials

  • I006-GFP-strong (Plasmid #108313, Addgene, Watertown, MA)
  • pFluoroGreen™ plasmid (Edvotek, Washington DC, Cat# 223-AP08)
  • E. coli strains: DH5α and BL21 for protein expression optimization

Computational Tools and Databases

  • PubChem Database (structural information and SMILES strings)
  • Benchling virtual restriction digest tool
  • Seven database reverse screening platform for protein-ligand interactions
  • PFOA SMILES correction: deprotonated form for accurate computational screening

Analytical Instrumentation

  • Microscale Thermophoresis (MST) for binding affinity determination
  • Differential Scanning Fluorimetry (DSF) for protein thermal stability
  • Size Exclusion Chromatography (SEC) for protein purification
  • SDS-PAGE gel electrophoresis for protein analysis
  • Analytical Ultracentrifugation (AUC) for oligomeric state determination
  • Circular Dichroism (CD) spectroscopy for protein folding validation
  • GelDoc imaging system for restriction digest analysis

Educational Resources

  • Khan Academy: Biology curriculum foundation
  • Study.com: Supplemental educational content
  • Educational Justice: School partnership program
  • Kentucky Science Center: Public engagement platform
  • NYU Abu Dhabi: Storybook collaboration partner
  • GloGerm simulation system for microbial education

IX. Future Work


Technical Development

Biosensor Engineering

  • Refinement of TYMS-based biosensor circuit design
  • Integration of PFOA detection assay with fluorescent output
  • Optimization of binding affinity through protein engineering
  • Development of field-deployable detection platform

Transcriptomics Analysis

  • Complete RNA-seq analysis for PFOA-responsive promoters
  • Rebalance library pooling ratios based on QC results
  • Repeat failed samples (#18, #24) with optimized protocols
  • Develop promoter library for next-generation genetic circuits
  • Validate promoter activity through fluorescence assays

Protein Characterization

  • Complete NMR analysis with optimized buffer conditions
  • Investigate monomer-dimer equilibrium in presence of PFOA
  • Structural studies of TYMS-PFOA complex
  • Kinetic analysis of binding interactions

Educational and Outreach Expansion

Curriculum Development

  • Expand biology curriculum to additional school districts
  • Develop advanced modules for high school AP biology
  • Create teacher training workshops for synthetic biology concepts
  • Design virtual learning modules for remote education

Public Engagement

  • Publication of "Milo the Monkey" environmental storybook
  • Expand science center activities to additional venues
  • Develop social media campaign for environmental awareness
  • Create citizen science programs for water quality monitoring

Partnership Development

  • Strengthen collaboration with NYU Abu Dhabi
  • Expand Educational Justice partnership
  • Develop industry partnerships for biosensor deployment
  • Create international educational exchange programs

Next Engineering Cycle Priorities

Immediate Goals (Next 6 months):

  1. Complete transcriptomics sequencing run with rebalanced libraries
  2. Optimize TYMS-GFP fusion protein production for scaled biosensor development
  3. Publish and distribute "Milo the Monkey" storybook
  4. Implement improved restriction enzyme protocols for genetic circuit validation

Long-term Vision (1-2 years):

  1. Deploy functional PFOA biosensor for field testing
  2. Establish comprehensive educational program across multiple institutions
  3. Contribute to global PFAS contamination monitoring efforts
  4. Develop next-generation synthetic biology tools for environmental detection
× Enlarged image